Sermorelin Peptides in USA Source legit

Growth hormone releasing peptides protocol log

Sermorelin Peptides in USA

Mechanism, dose window, half-life, stack pairing, sourcing pathway. The sermorelin entry, plus adjacent GHRPs and GHRH analogs adults actually run.

Source from a US licensed provider

Sermorelin, profile entry

A 29 amino acid GHRH analog that binds the same pituitary receptor as endogenous growth hormone releasing hormone. Triggers a physiologic pulse of growth hormone in the body's own pattern, while the natural negative feedback loop stays intact. Approved branded form discontinued. Modern administration is compounded, prescription only, from US 503A and 503B pharmacies.

Mechanism

Binds pituitary GHRH receptor, triggers pulsatile GH release. Feedback loop preserved.

Dose window

100 to 500 mcg subcutaneous nightly. Most US telehealth protocols sit at 200 to 300 mcg.

Cycle length

12 weeks standard. Re-evaluate IGF-1 at week 12. Off-cycle 4 to 8 weeks if continuing.

Lab markers

IGF-1, fasting glucose, HbA1c, lipids, basic metabolic panel.

Common stack

Sermorelin GHRH plus ipamorelin GHRP for synergistic pulse amplification.

Side effect floor

Injection site redness, transient flush, occasional headache. Hypoglycemia screened.

Adjacent peptides commonly stacked

Sermorelin rarely runs alone in serious protocols. The two adjacent classes worth understanding are GHRPs, which amplify GH pulse amplitude, and longer half-life GHRH analogs, which extend the pulse window. The table below summarizes the field. None of these are sold legally without prescription in the US.

Peptide Class Half life Typical role
Sermorelin GHRH analog 10 to 20 min Restore natural overnight pulse
Tesamorelin GHRH analog, modified 26 min in serum Stronger pulse, FDA approved for HIV lipodystrophy
CJC 1295 with DAC GHRH analog, long acting Days, not minutes Sustained elevation, loses pulsatility
Ipamorelin GHRP, selective 2 hours Pulse amplification, minimal cortisol or prolactin
GHRP 2 GHRP 1 to 2 hours Pulse amplification, mild appetite increase
Hexarelin GHRP Approx 1 hour Strong pulse but blunts response over time, rarely used long term

The cycle protocol

A standard 12 week sermorelin run looks like the schedule below. Adjust dose by clinician, not by self-titration. The five-on-two-off cadence reduces tachyphylaxis at the pituitary GHRH receptor over a long cycle.

Week Dose Cadence Lab check Notes
1 to 4 200 mcg 5 on, 2 off Baseline IGF-1 done Sleep depth shifts first. Hold steady.
5 to 8 200 to 300 mcg 5 on, 2 off None mid cycle Skin, hair, energy. Training recovery up.
9 to 12 300 mcg 5 on, 2 off Follow up IGF-1 at week 12 Body composition window. Reassess.
Week 13 Pause or maintain Clinician call Compare IGF-1 to baseline Decide hold, lower, or cycle off 4 to 8 weeks.

Sourcing pathway in the United States

There are two channels for sermorelin in the US. One is legal, clinical, and traceable. The other is not, and is sold under a research-only label that buyers routinely ignore. The difference matters for purity, dose accuracy, and personal legal exposure.

Clinical pathway

Compounded prescription

  • Online consultation with a licensed clinician in your state
  • Baseline IGF-1 plus metabolic panel ordered
  • Prescription dispensed by a 503A or 503B compounding pharmacy
  • Sterile vial, accurate concentration, traceable batch
  • Sharps kit, dosing protocol, follow-up labs

View licensed provider

Research-only pathway

Grey market peptide vendor

  • Sold as research chemical, not for human consumption
  • No clinician oversight, no prescription, no liability
  • Purity and dose vary by batch and supplier
  • No medical record, no lab follow-up
  • Federal grey area for buyer, frank illegal for some sellers

Not recommended for any adult running protocols seriously.

Self-tracking log, what to measure

Sermorelin works on a slow curve. The signal arrives over weeks, not days, and shows up unevenly across markers. The tracking spec below catches the typical response without over-instrumenting.

  • Sleep depth, weeks 1 to 4

    Wearable deep sleep minutes, subjective restfulness on waking. Most consistent first signal.

  • Morning energy, weeks 1 to 4

    Subjective on a 1 to 10 scale at the same time each morning. Daily, no trend smoothing the first month.

  • Training recovery, weeks 4 to 8

    Time to feel ready for the next session after a hard lift or run. Notes on DOMS duration.

  • Body composition, weeks 8 to 12

    Same day of week, same time of day, same equipment. Waist circumference and weight at minimum. DEXA if possible at baseline and end.

  • IGF-1, week 12

    Follow up draw. Compare to baseline. This is the only objective biochemical signal the protocol moves predictably.

  • Fasting glucose, monthly

    Safety marker. GH downstream can shift insulin sensitivity. Flag any sustained rise.

Source it through a US licensed clinic

Compounded sermorelin from a registered pharmacy, after a real consultation and lab. Refund if the clinician says no.

View US licensed provider